Description
Baricitinib carries an FDA boxed warning shared across JAK inhibitors: increased risk of serious infections, all-cause mortality, malignancies (including lymphoma), major adverse cardiovascular events, and thrombosis (blood clots). Tuberculosis screening is required before starting.
Is Baricinix 4 mg right for your situation?
Review these criteria with your physician before enquiring- ✓Moderately to severely active rheumatoid arthritis with inadequate response to one or more TNF inhibitors
- ✓Severe alopecia areata (50%+ scalp hair loss), especially if the 2 mg dose was inadequate
- ✓Prescribed the 4 mg strength specifically by your physician
- ✓Need a WHO-GMP generic alternative to Olumiant® made by Beacon
- ✗Prescribed a 2 mg dose — this 4 mg tablet cannot be safely split to achieve that dose without your physician’s explicit direction
- ✗Active or untreated latent tuberculosis, or other active serious infection
- ✗Age 50+ with cardiovascular risk factors, without careful risk-benefit discussion
- ✗Pregnant, planning pregnancy, or breastfeeding
Check Availability & Pricing
Prescription required · Named Patient Program · Worldwide shipping
🛡 WHO-GMP Certified · Prescription verified · Express dispatch
What is Baricinix 4 mg?
Baricinix 4 mg is a generic formulation of Baricitinib — an oral JAK1/JAK2 inhibitor — manufactured by Beacon Pharmaceuticals Ltd., Bangladesh’s largest dedicated oncology pharmaceutical company, under WHO-GMP certified conditions. Each tablet contains 4 mg of baricitinib, the same active molecule found in Olumiant® (Eli Lilly), and is dispensed under the Named Patient Program.
Important: Baricitinib is approved at both 2 mg and 4 mg doses depending on indication, prior treatment response, and country-specific labelling. This product is the 4 mg strength. If your physician has prescribed 2 mg, confirm with them exactly how this should be sourced or dosed — do not assume a 4 mg tablet can simply be halved unless your physician explicitly confirms this is appropriate for the specific formulation.
| Generic name | Baricitinib |
| Reference brand | Olumiant® (Eli Lilly) |
| Manufacturer | Beacon Pharmaceuticals Ltd. |
| Standard | WHO-GMP Certified |
| Drug class | JAK1/JAK2 Inhibitor |
| Dosage form | Tablet — 4 mg |
| Pack size | 30 tablets per pack |
| Route | Oral · once daily, with or without food |
| Prescription | Required — physician only |
How Baricitinib Works
In rheumatoid arthritis and alopecia areata, the immune system attacks the body’s own tissue — joints in RA, hair follicles in alopecia areata — driven by inflammatory cytokines signalling through JAK1 and JAK2 pathways.
Dosing by Indication
| Rheumatoid arthritis | 2 mg once daily (standard); 4 mg only for patients with inadequate response to ≥2 DMARDs, per physician judgement |
| Severe alopecia areata | 2 mg once daily initially; may increase to 4 mg once daily if response is inadequate |
| Hospitalised COVID-19 | 4 mg once daily for up to 14 days, per hospital protocol |
Because Baricinix is supplied as a 4 mg tablet, patients prescribed 2 mg should confirm with their physician exactly which product/strength combination is appropriate — do not self-adjust dosing.
Side Effects
Common · Usually Manageable
- Upper respiratory tract infections
- Nausea, headache
- Herpes simplex / herpes zoster reactivation
- Acne
- Elevated cholesterol
Serious · Report Immediately
- Serious infections (including TB reactivation)
- Venous and arterial thromboembolic events
- Malignancy (including lymphoma)
- Major adverse cardiovascular events
- Gastrointestinal perforation (rare)
- Fever, chills, or signs of infection not resolving normally
- Sudden leg swelling/pain, chest pain, or breathlessness (possible blood clot)
- Signs of TB reactivation (persistent cough, weight loss, night sweats)
How to Take Baricinix 4 mg
- 1Once daily, with or without food. Take exactly as prescribed for your specific indication.
- 2Swallow tablet whole with water. Do not crush or chew.
- 3TB screening must be completed before starting, and periodically during treatment as advised.
- 4Do not start during an active infection — contact your physician if you develop infection symptoms.
- 5Storage: dry place, away from direct sunlight, out of reach of children.
Frequently Asked Questions
My doctor prescribed 2 mg — can I still order Baricinix 4 mg?
Why does baricitinib have a boxed warning?
Do I need tuberculosis testing before starting Baricinix?
How do I order Baricinix through Meds For Cancer?
Meds For Cancer operates as a Named Patient Program (NPP) facilitator. WHO-GMP certified medicines are made available to individual patients with a confirmed medical need and a valid prescription, in countries where the branded product is unavailable or unaffordable.
- Taylor PC, et al. Baricitinib versus placebo or adalimumab in rheumatoid arthritis (RA-BEAM). NEJM 2017;376:652–662.
- King B, et al. Two Phase 3 trials of baricitinib for alopecia areata. NEJM 2022;386:1687–1699.
- FDA Prescribing Information: Olumiant (baricitinib), including Boxed Warning. Eli Lilly, 2023.
